Motorpoint Group PLC (MOTR) Given “Buy” Rating at Numis Securities Ltd

Motorpoint Group PLC (LON:MOTR)‘s stock had its “buy” rating reiterated by research analysts at Numis Securities Ltd in a research report issued to clients and investors on Wednesday. They currently have a GBX 250 ($3.05) target price on the stock. Numis Securities Ltd’s price objective indicates a potential upside of 49.70% from the company’s current price.

Motorpoint Group PLC (LON:MOTR) traded down 22.97% during midday trading on Wednesday, hitting GBX 128.64. 818,129 shares of the stock were exchanged. Motorpoint Group PLC has a 1-year low of GBX 128.00 and a 1-year high of GBX 245.50. The company’s 50 day moving average is GBX 196.09 and its 200 day moving average is GBX 206.60. The company’s market capitalization is GBX 128.64 million.

About Motorpoint Group PLC

Motorpoint Group plc is an independent vehicle retailer. The Company’s primary business is the sale of vehicles, of which are approximately two years old and which have covered approximately 15,000 miles. The Company sells vehicles from brands representing vehicle sales in the United Kingdom, with models, such as Ford, Vauxhall, Volkswagen, Hyundai and Audi.

Receive News & Ratings for Motorpoint Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motorpoint Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Eli Lilly Alzheimer’s Drug Does Not Pass the Test


 
© 2006-2016 Ticker Report. Google+.